Latest Insider Transactions at Syndax Pharmaceuticals Inc (SNDX)
This section provides a real-time view of insider transactions for Syndax Pharmaceuticals Inc (SNDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Syndax Pharmaceuticals Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Syndax Pharmaceuticals Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 06
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,231
-47.89%
|
$405,775
$25.29 P/Share
|
|
Oct 06
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,231
+32.38%
|
$129,848
$8.77 P/Share
|
|
Oct 06
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
29,899
-30.77%
|
$747,475
$25.9 P/Share
|
|
Oct 06
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
29,899
+23.2%
|
$239,192
$8.41 P/Share
|
|
Oct 04
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,280
-6.76%
|
$32,000
$25.02 P/Share
|
|
Oct 04
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,280
+6.33%
|
$10,240
$8.77 P/Share
|
|
Oct 04
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
360
-0.56%
|
$9,000
$25.0 P/Share
|
|
Oct 04
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
360
+0.56%
|
$2,880
$8.41 P/Share
|
|
Oct 03
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,883
-14.03%
|
$72,075
$25.01 P/Share
|
|
Oct 03
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,883
+12.31%
|
$23,064
$8.77 P/Share
|
|
Oct 03
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
180
-0.28%
|
$4,500
$25.0 P/Share
|
|
Oct 03
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
180
+0.28%
|
$1,440
$8.41 P/Share
|
|
Sep 30
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
29,606
-62.64%
|
$740,150
$25.02 P/Share
|
|
Sep 30
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,606
+38.51%
|
$236,848
$8.77 P/Share
|
|
Sep 30
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
3,561
-5.16%
|
$89,025
$25.07 P/Share
|
|
Sep 30
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
3,561
+4.82%
|
$28,488
$8.41 P/Share
|
|
Sep 20
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
59,649
-76.98%
|
$1,371,927
$23.25 P/Share
|
|
Sep 20
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
59,649
+43.5%
|
$596,490
$10.9 P/Share
|
|
Sep 19
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
114,339
-86.51%
|
$2,629,797
$23.03 P/Share
|
|
Sep 19
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
114,339
+46.38%
|
$1,143,390
$10.9 P/Share
|
|
Sep 16
2022
|
Dennis Podlesak |
SELL
Open market or private sale
|
Direct |
11,975
-7.32%
|
$275,425
$23.43 P/Share
|
|
Sep 16
2022
|
Dennis Podlesak |
BUY
Exercise of conversion of derivative security
|
Direct |
11,975
+6.82%
|
$71,850
$6.34 P/Share
|
|
Sep 16
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
125,000
-77.49%
|
$2,875,000
$23.22 P/Share
|
|
Sep 16
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+43.64%
|
$1,125,000
$9.05 P/Share
|
|
Sep 15
2022
|
Dennis Podlesak |
SELL
Open market or private sale
|
Direct |
66,840
-46.87%
|
$1,604,160
$24.2 P/Share
|
|
Sep 15
2022
|
Dennis Podlesak |
BUY
Exercise of conversion of derivative security
|
Direct |
66,840
+31.91%
|
$401,040
$6.32 P/Share
|
|
Sep 15
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
66,775
-78.92%
|
$1,602,600
$24.2 P/Share
|
|
Sep 15
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
66,775
+44.11%
|
$467,425
$7.2 P/Share
|
|
Sep 14
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
87,645
-83.09%
|
$2,015,835
$23.8 P/Share
|
|
Sep 14
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
87,645
+45.38%
|
$613,515
$7.2 P/Share
|
|
Aug 24
2022
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-93.95%
|
$625,000
$25.04 P/Share
|
|
Aug 24
2022
|
Peter Ordentlich Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+48.41%
|
$150,000
$6.34 P/Share
|
|
Aug 05
2022
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
24,000
-27.12%
|
$552,000
$23.02 P/Share
|
|
Aug 05
2022
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+21.28%
|
$216,000
$9.28 P/Share
|
|
Jul 29
2022
|
Peter Ordentlich Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
265
+50.0%
|
$3,710
$14.12 P/Share
|
|
Jul 25
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
31,602
-46.47%
|
$663,642
$21.06 P/Share
|
|
Jul 25
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,602
+31.6%
|
$189,612
$6.38 P/Share
|
|
Jul 07
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100
-0.56%
|
$2,100
$21.0 P/Share
|
|
Jul 07
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.56%
|
$600
$6.38 P/Share
|
|
Jul 06
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,009
-45.94%
|
$315,189
$21.07 P/Share
|
|
Jul 06
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,009
+31.48%
|
$90,054
$6.38 P/Share
|
|
Jul 01
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
62,292
-77.74%
|
$1,183,548
$19.0 P/Share
|
|
Jul 01
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
62,292
+43.74%
|
$436,044
$7.2 P/Share
|
|
Jun 13
2022
|
Keith A. Goldan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,205
+50.0%
|
-
|
|
Apr 04
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
3,128
-14.92%
|
$56,304
$18.29 P/Share
|
|
Apr 04
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
3,128
+12.98%
|
$31,280
$10.9 P/Share
|
|
Apr 01
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
101,045
-50.03%
|
$1,717,765
$17.45 P/Share
|
|
Apr 01
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
70,545
+44.39%
|
$705,450
$10.9 P/Share
|
|
Feb 02
2022
|
Martin H. Huber Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+50.0%
|
-
|
|
Feb 02
2022
|
William Meury |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+33.33%
|
-
|